CLA Global TS Successfully Supported Singapore Institute of Advanced Medicine Holdings in its IPO Listing on SGX

Singapore, 16 February 2024 – CLA Global TS is pleased to announce that the firm has successfully supported healthcare service provider Singapore Institute of Advanced Medicine (SAM) Holdings in its initial public offering (IPO) listing on the Catalist board of the Singapore Exchange (SGX).

SAM focuses on diagnosing and treating various diseases and health conditions, including cancer as well as neurodegenerative and cardiovascular diseases. Through its clinics in Biopolis Drive and Lucky Plaza, it offers a suite of services, including radiotherapy, diagnostic imaging, theranostic services, as well as radiopharmaceutical and oncology services for the early treatment of cancer and other diseases.

CLA Global TS was appointed as the risk advisory firm supporting the IPO listing through its pre-IPO internal control review.

Mr. Paul Yeo, Executive Director & Chief Operating Officer, Singapore Institute of Advanced Medicine Holdings said, “Our company engaged CLA Global TS as our internal auditor in preparation for our IPO listing. The team has successfully assisted our group in reviewing the adequacy and effectiveness of our internal controls. The reviews were conducted professionally and was completed in a timely manner, and they provided good and practical recommendations to enhance our internal controls. We are thankful for the team’s dedication and advice throughout the engagement.”

Mr. Henry Tan, Group CEO & Chief Innovation Officer, CLA Global TS, said, “Our heartiest congratulations to Singapore Institute of Advanced Medicine (SAM) Holdings for the successful IPO listing. We are glad to be entrusted with this important task of reviewing and improving SAM’s internal control system. On behalf of the Risk Advisory team, we wish SAM continued success in revolutionising healthcare for cancer patients and maximising your business growth.”

 

View the full article in PDF here.

 

About Singapore Institute of Advanced Medicine Holdings Ltd.:

Incorporated in 2011 and founded by Dr Djeng Shih Kien, SIAMH focuses on diagnosing and treating various diseases and health conditions, including cancer as well as neurodegenerative and cardiovascular diseases. Through its clinics in Biopolis Drive and Lucky Plaza, it offers a suite of services, including radiotherapy, diagnostic imaging, theranostic services as well as radiopharmaceutical and oncology for the early treatment of cancer and other diseases.

For more information, visit https://advancedmedicine.sg.

 

About CLA Global TS:

Founded in 1993, CLA Global TS, is an award-winning Asia-Centred Business Advisor. An independent member firm of CLA Global Network, CLA Global TS provides a full spectrum of professional services including, but not limited to Assurance & IPO Reporting, Tax, Risk Advisory, Valuation, Insolvency & Restructuring, Sustainability & Climate Change Advisory and more.

For more information, visit CLA-TS.com.

 

Media Contacts:

Ross Seah
Marketing Communications Manager
+65 6534 5700 (ext. 707)
rossseah@sg.cla-ts.com

Danial Lee
Marketing Communications Associate
+65 6534 5700 (ext. 861)
daniallee@sg.cla-ts.com

Share this Article

Recent Articles

GET A QUOTE